Atea Pharmaceuticals, Inc. (AVIR) — Stock Score Summary

Atea Pharmaceuticals, Inc. (AVIR) has a MoatMap StockRank of 49/100 based on Quality (34/100), Value (39/100), and Momentum (63/100) factor scores. The current signal is HOLD. Atea Pharmaceuticals is a clinical-stage biopharma company with no commercialized products, representing a speculative binary bet rather than a quality compounder.

Atea Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics for life-threatening viral infections like COVID-19 and dengue. Its proprietary nucleotide prodrug platform for antiviral drug discovery offers potential for broad-spectrum antiviral activity and addresses significant unmet medical needs. Atea is a specialized biotech company dedicated to antiviral drug development, with a focus on novel mechanisms of action.

Key Financial Metrics

Price$4.36
Market Cap$379M
P/E (Forward)-3.19
Price/Book1.51
Return on Equity-52.6%
Return on Invested Capital-65.7%
Debt/Equity0.27
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-88M

Atea Pharmaceuticals, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Atea Pharmaceuticals, Inc.’s (AVIR) StockRank?
MoatMap’s StockRank for Atea Pharmaceuticals, Inc. (AVIR) is 49/100, with a Hold signal. It is a composite of Quality (34), Value (39), and Momentum (63) factor ranks across MoatMap’s 19,000+ stock universe.
Does Atea Pharmaceuticals, Inc. have an economic moat?
Atea Pharmaceuticals, Inc. (AVIR) has a Quality factor score of 34/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Atea Pharmaceuticals, Inc. a buy, hold, or sell?
MoatMap’s current signal for Atea Pharmaceuticals, Inc. (AVIR) is Hold, based on a StockRank of 49/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Atea Pharmaceuticals, Inc. in?
Atea Pharmaceuticals, Inc. (AVIR) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksAVIR deep dive reportAI ChampionsHow we score stocksSense-check another stock